These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 25924769)
1. Circulating miRNAs miR-34a and miR-150 associated with colorectal cancer progression. Aherne ST; Madden SF; Hughes DJ; Pardini B; Naccarati A; Levy M; Vodicka P; Neary P; Dowling P; Clynes M BMC Cancer; 2015 Apr; 15():329. PubMed ID: 25924769 [TBL] [Abstract][Full Text] [Related]
2. A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer. Kanaan Z; Roberts H; Eichenberger MR; Billeter A; Ocheretner G; Pan J; Rai SN; Jorden J; Williford A; Galandiuk S Ann Surg; 2013 Sep; 258(3):400-8. PubMed ID: 24022433 [TBL] [Abstract][Full Text] [Related]
3. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer. Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702 [TBL] [Abstract][Full Text] [Related]
4. Comparison of Circulating miRNAs Expression Alterations in Matched Tissue and Plasma Samples During Colorectal Cancer Progression. Nagy ZB; Barták BK; Kalmár A; Galamb O; Wichmann B; Dank M; Igaz P; Tulassay Z; Molnár B Pathol Oncol Res; 2019 Jan; 25(1):97-105. PubMed ID: 28980150 [TBL] [Abstract][Full Text] [Related]
5. Combined Plasma MicroRNA and Fecal Occult Blood Tests in Early Detection of Colorectal Cancer. Luo X; Wu Y; Ji M; Zhang S Clin Lab; 2019 May; 65(5):. PubMed ID: 31115212 [TBL] [Abstract][Full Text] [Related]
6. Plasma miR-601 and miR-760 are novel biomarkers for the early detection of colorectal cancer. Wang Q; Huang Z; Ni S; Xiao X; Xu Q; Wang L; Huang D; Tan C; Sheng W; Du X PLoS One; 2012; 7(9):e44398. PubMed ID: 22970209 [TBL] [Abstract][Full Text] [Related]
7. Examining plasma microRNA markers for colorectal cancer at different stages. Sun Y; Liu Y; Cogdell D; Calin GA; Sun B; Kopetz S; Hamilton SR; Zhang W Oncotarget; 2016 Mar; 7(10):11434-49. PubMed ID: 26863633 [TBL] [Abstract][Full Text] [Related]
8. Serum microRNA-135a-5p as an auxiliary diagnostic biomarker for colorectal cancer. Wang Q; Zhang H; Shen X; Ju S Ann Clin Biochem; 2017 Jan; 54(1):76-85. PubMed ID: 27126269 [TBL] [Abstract][Full Text] [Related]
9. Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1α-VEGF signaling pathway. Sabry D; El-Deek SEM; Maher M; El-Baz MAH; El-Bader HM; Amer E; Hassan EA; Fathy W; El-Deek HEM Mol Cell Biochem; 2019 Apr; 454(1-2):177-189. PubMed ID: 30357530 [TBL] [Abstract][Full Text] [Related]
10. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma. Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223 [TBL] [Abstract][Full Text] [Related]
11. Identification and evaluation of plasma microRNAs for early detection of colorectal cancer. Luo X; Stock C; Burwinkel B; Brenner H PLoS One; 2013; 8(5):e62880. PubMed ID: 23690963 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection. Chang PY; Chen CC; Chang YS; Tsai WS; You JF; Lin GP; Chen TW; Chen JS; Chan EC Oncotarget; 2016 Mar; 7(9):10663-75. PubMed ID: 26848774 [TBL] [Abstract][Full Text] [Related]
13. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer. Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic Potential of Cell-Free and Exosomal MicroRNAs in the Identification of Patients with High-Risk Colorectal Adenomas. Uratani R; Toiyama Y; Kitajima T; Kawamura M; Hiro J; Kobayashi M; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Goel A; Kusunoki M PLoS One; 2016; 11(10):e0160722. PubMed ID: 27760147 [TBL] [Abstract][Full Text] [Related]
15. Circulating miR-34a levels are reduced in colorectal cancer. Nugent M; Miller N; Kerin MJ J Surg Oncol; 2012 Dec; 106(8):947-52. PubMed ID: 22648208 [TBL] [Abstract][Full Text] [Related]
16. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Ng EK; Chong WW; Jin H; Lam EK; Shin VY; Yu J; Poon TC; Ng SS; Sung JJ Gut; 2009 Oct; 58(10):1375-81. PubMed ID: 19201770 [TBL] [Abstract][Full Text] [Related]
17. The use of circulating microRNAs as diagnostic biomarkers in colorectal cancer. Clancy C; Joyce MR; Kerin MJ Cancer Biomark; 2015; 15(2):103-13. PubMed ID: 25547322 [TBL] [Abstract][Full Text] [Related]
18. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Huang Z; Huang D; Ni S; Peng Z; Sheng W; Du X Int J Cancer; 2010 Jul; 127(1):118-26. PubMed ID: 19876917 [TBL] [Abstract][Full Text] [Related]
19. Rare circulating microRNAs as biomarkers of colorectal neoplasia. Adams SV; Newcomb PA; Burnett-Hartman AN; Wurscher MA; Mandelson M; Upton MP; Zhu LC; Potter JD; Makar KW PLoS One; 2014; 9(10):e108668. PubMed ID: 25286412 [TBL] [Abstract][Full Text] [Related]